Abstracts and Articles

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes.

Thomas Nick (N);Vaidya Bijay (B);Leslie Richard David (RD);Agardh Daniel (D);Oram Richard (R);Dabelea Dana (D);Singh Arunjot (A);Chantzichristos Dimitrios (D);Rewers Marian (M)

Initial allergenicity assessment of Ulva sp. seaweed flour.

Kedar Odeya (O);Golberg Alexander (A);Obolski Uri (U);Steinbruch Efraim (E);Chemodanov Alexander (A);Israel Álvaro (Á);Livney Yoav D (YD);Lachover-Roth Idit (I);Rosman Yossi (Y);Confino-Cohen Ronit (R)

Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United States.

Kumar Sonal (S);Shamseddine Nisreen (N);Yang Hongbo (H);Zhang Su (S);Ye Dongni (D);Seshasayee Shravanthi (S);Chen Jingyi (J);Kowdley Kris V (KV)

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications.

El-Azab Gasser (G);Elkhouly Ehab (E);Abouyoussef Rania (R);Nagdy Hanaa (H)

Percutaneous Balloon Compression Exerts Multidimensional Efficacy in Trigeminal Neuralgia via Neuroinflammation and Neurotransmitter Regulation.

Du Yihui (Y);Shi Haowei (H);Xi Zenghui (Z);Wang Yinzhan (Y);Guo Wenchang (W);Qian Tao (T)

Gen Z and Safe Sex Practices: Drivers of Condom Purchase Intention in an Emerging Country.

Cao Viet Quoc (VQ);Trinh Nhung (N);Tang-Le Hung Thanh (HT)

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025.

Tanaka Atsushi (A);Treeprasertsuk Sombat (S);Chang Ming-Ling (ML);Tan Soek-Siam (SS);Efe Cumali (C);Jeong Sook-Hyang (SH);Ma Xiong (X);Weltman Martin (M);Isayama Hiroyuki (H);Jia Jidong (J)

Efficacy and safety of iclepertin for cognitive impairment associated with schizophrenia (CONNEX programme): results from three phase 3 randomised controlled trials.

Keefe Richard S E (RSE);Harvey Philip D (PD);Correll Christoph U (CU);Falkai Peter (P);Hashimoto Naoki (N);Klein Hans (H);Krystal John H (JH);Marder Stephen (S);Medalia Alice (A);Sumiyoshi Tomiki (T);Wang Gang (G);Zhang Hongyan (H);Blahova Zuzana (Z);Bichard-Sall Ingrid (I);English Brett A (BA);Fu Eric (E);Gruenenfelder Fredrik (F);Groeschl Martina (M);Kimura Karen (K);Tang Wenbo (W);von der Goltz Christoph (C);Fowler Corey (C)

AMA-Negative Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome Presenting With Bullous Pemphigoid: A Case Report.

Haque Tahmina (T);Ansari Rafay Shahab (RS);Rahman Ashiqur (A);Gul Fahad (F);Fareed Ashan (A);Qayyum Sardar Noman (SN)

Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation.

Rogalska Magdalena (M);Błachnio-Zabielska Agnieszka (A);Zabielski Piotr (P);Janica Jacek (J);Roszczyc-Owsiejczuk Kamila (K);Pogodzińska Karolina (K);Andrzejuk Aleksandra (A);Dąbrowski Andrzej (A);Flisiak Robert (R);Rogalski Paweł (P)

JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.

Kobayashi Takashi (T);Kitamura Hiroshi (H);Furukawa Yuka (Y);Shono Michihiro (M);Ito Takayuki (T);Kikuchi Eiji (E)

Hydroxyapatite-Modified Biochar Application Derived from Recycled Selenium-Rich Straw Enhances Rice Biofortification and Economic Benefits.

Guan Haoran (H);Lv Yuke (Y);Wang Kai (K);Zhang Henglei (H);Xu Jianming (J);Liu Xingmei (X)

An Encapsulated Vitamin A Palmitate Powder With Improved Stability for Use in Food Fortification.

Brady Samantha (S);Jaoude Elsa Abou (EA);Wyns Julie (J);Yang Haisong (H);Ebbesen Justyna (J);Ivarsen Elise (E);Straub Julie (J);Vallejo Jérôme (J);Chickering Don (D)

Proteomics identifies complement protein signatures in patients with primary biliary cholangitis.

Ma Xiaolin (X);Dong Hang (H);Han Junming (J);Han Ming (M);Zhang Teng (T);Zhou Meng (M);Fan Xiude (X);Liu Luna (L);Wang Zhen (Z)

Systemic PCSK9 elevation characterises autoimmune liver disease across sexes.

Mester Patricia (P);Pavel Vlad (V);Stoeckert Petra (P);Müller Martina (M);Tews Hauke Christian (HC);Buechler Christa (C)

Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision.

Choi Gina (G);Jesudian Arun B (AB);Saab Sammy (S)

Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.

Vierling John M (JM);Hirschfield Gideon M (GM);Kustra Robert P (RP);Liu Xiangyu (X);Proehl Sarah (S);Crittenden Daria B (DB)

Profile of Patients with Primary Biliary Cholangitis and Evaluation of Response to Ursodeoxycholic Acid in a Romanian Center-Retrospective Study.

Mandea Matei (M);Iacob Speranta M (SM);Ghioca Mihaela C (MC);Gheorghe Cristian (C);Gheorghe Liliana S (LS)